Endothelium-derived contracting factor: A new way of looking at endothelial function in obesity

Journal of Hypertension

Volumn 20, Issue 11, 2002, Pages 2147-2149

  Gollasch, Maik ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED CONSTRICTING FACTOR; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2 RECEPTOR; BIOLOGICAL FACTOR; ENDOTHELIN; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR;

ARTERY TONE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MOUSE; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; PATHOPHYSIOLOGY; PHYSIOLOGY;

BIOLOGICAL FACTORS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; HUMANS; OBESITY;

EID: 0036854824     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200211000-00011     Document Type: Note

References (17)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
2. Haller H. Modulation of endothelial function: Strategy for long-term cardiovascular protection. J Hypertens Suppl 1996; 14:S27-S32.
3. Campbell WB, Harder DR. Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol 2001; 280:H2413-H2146.
4. Lauterbach B, Barbosa-Sicard E, Wang MH, Honeck H, Kargel E, Theuer J, et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 2002; 39:609-613.
5. Corriu C, Feletou M, Edwards G, Weston AH, Vanhoutte PM. Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig. Eur J Pharmacol 2001; 24:89-94.
6. + currents in human coronary artery vascular smooth muscle cells. Circ Res 1996; 78: 676-688.
7. Bychkov R, Gollasch M, Steinke T, Ried C, Luft FC, Haller H. Calcium-activated potassium channels and nitrate-induced vasodilation in human coronary arteries. J Pharmacol Exp Ther 1998; 285:293-298.
8. 2+) spark/STOC coupling and elevated blood pressure. Circ Res 2000; 24:E53-E60.
9. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 1991; 18 (suppl 5):III86-III92
10. Lüscher TF, Boulanger CM, Dohi Y, Yang ZH. Endothelium-derived contracting factors. Hypertension 1992; 19:117-130.
11. Busse R, Fleming I. Nitric oxide, nitric oxide synthase, and hypertensive vascular disease. Curr Hypertens Rep 1999; 1:88-95.
12. De Mey JG, Vanhoutte PM. Contribution of the endothelium to the response to anoxia in the canine femoral artery. Arch Int Pharmacodyn Ther 1981; 253:325-326.
13. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, Barton M. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 2002; 20: 2239-2245.
14. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16:1057-1063.
15. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: Mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 2002; 26:754-764.
16. Esposito K, Nicoletti G, Giugliano D. Obesity, cytokines and endothelial dysfunction: A link for the raised cardiovascular risk associated with visceral obesity. J Endocrinol Invest 2002; 25:646-649.
17. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 1: 305-313.